Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 6/20 | 0.35 |
| ▸ | LDHA | P00338 | 3/20 | 0.35 |
| ▸ | LDHB | P07195 | 3/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27671375 | 0.85 | METAP2 (0.37) | L3MBTL1TDP1SMN1; SMN2METAP2LDHA | |
| SCHEMBL10456939 | 0.84 | METAP2 (0.47) | L3MBTL1TDP1SMN1; SMN2METAP2LDHA | |
| SCHEMBL15957663 | 0.82 | METAP2 (0.48) | L3MBTL1TDP1SMN1; SMN2METAP2LDHA | |
| SCHEMBL14783306 | 0.81 | L3MBTL1 (0.36) | L3MBTL1TDP1SMN1; SMN2METAP2LDHA | |
| SCHEMBL8923355 | 0.81 | SMN1; SMN2 (0.50) | L3MBTL1TDP1SMN1; SMN2KDM4ECYP3A4 | |
| SCHEMBL8793515 | 0.81 | PON1 (0.39) | L3MBTL1TDP1SMN1; SMN2METAP2LDHA | |
| Hydrochloric Acid SCHEMBL27837550 | 0.79 | L3MBTL1 (0.35) | L3MBTL1TDP1SMN1; SMN2METAP2LDHA | |
| SCHEMBL6122759 | 0.79 | NOTUM (0.33) | L3MBTL1TDP1SMN1; SMN2LDHALDHB | |
| SCHEMBL1686189 | 0.79 | CA12 (0.47) | TDP1SMN1; SMN2KDM4ECYP3A4POLB | |
| SCHEMBL28931615 | 0.78 | TAAR1 (0.43) | L3MBTL1TDP1SMN1; SMN2METAP2LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3303415-B1 | VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF | ALCON INC (CH) | 2022-12-28 | — | — | EP | disclosed |
| US-10324311-B2 | Visible-light photoinitiators and uses thereof | NOVARTIS AG (CH) | 2019-06-18 | — | — | US | disclosed |
| EP-3303415-A1 | VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF | Novartis AG (CH) | 2018-04-11 | — | — | EP | disclosed |
| US-20160357031-A1 | VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF | ALCON INC. (CH) | 2016-12-08 | — | — | US | disclosed |
| WO-2016193912-A1 | VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF | NOVARTIS AG (CH) | 2016-12-08 | — | — | WO | disclosed |
| US-4409227-A | HYPOGLYCEMIC AGENTS | THE DOW CHEMICAL CO. (US) | 1983-10-11 | — | — | US | disclosed |
| US-4325959-A | Hypoglycemic 4-(((1,3,4, thiadiazolyl)thio)methyl)benzoic acids, ester and amides | THE DOW CHEMICAL COMPANY (US) | 1982-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10324311-B2 | Visible-light photoinitiators and uses thereof | SIRT5, IK, IGLV6-57 | L3MBTL1 1275/4885TDP1 4374/4885SMN1; SMN2 4875/4885 |
| US-20160357031-A1 | VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF | SIRT5, IK, IGLV6-57 | L3MBTL1 1275/4885TDP1 4374/4885SMN1; SMN2 4875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.